Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03769155
Brief Title: VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma

First Submitted : December 6, 2018
First Submitted that Met QC Criteria : December 6, 2018
First Posted : December 7, 2018

Last Update Submitted that Met QC Criteria : November 19, 2020
Last Update Posted : November 23, 2020